Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis

Heart failure (HF) screening strategies require biomarkers to predict disease manifestation to aid HF surveillance and management programmes. The aim of this study was to validate a previous proteomics discovery programme that identified Tetranectin as a potential HF biomarker candidate based on exp...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Kenneth, Glezeva, Nadezhda, Collier, Patrick, O’Reilly, James, O’Connell, Eoin, Tea, Isaac, Russell-Hallinan, Adam, Tonry, Claire, Pennington, Steve, Gallagher, Joe, Ledwidge, Mark, Baugh, John, Watson, Chris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200823/
https://www.ncbi.nlm.nih.gov/pubmed/32371911
http://dx.doi.org/10.1038/s41598-020-64558-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200823/
https://www.ncbi.nlm.nih.gov/pubmed/32371911
http://dx.doi.org/10.1038/s41598-020-64558-4

Ejemplares similares